0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.74%
Positive revenue growth while 0259.HK is negative. John Neff might see a notable competitive edge here.
44.00%
Positive gross profit growth while 0259.HK is negative. John Neff would see a clear operational edge over the competitor.
175.08%
Positive EBIT growth while 0259.HK is negative. John Neff might see a substantial edge in operational management.
175.08%
Positive operating income growth while 0259.HK is negative. John Neff might view this as a competitive edge in operations.
228.07%
Net income growth above 1.5x 0259.HK's 6.50%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
228.28%
EPS growth above 1.5x 0259.HK's 6.45%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
228.28%
Diluted EPS growth above 1.5x 0259.HK's 10.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.00%
Slight or no buybacks while 0259.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-99.98%
Dividend reduction while 0259.HK stands at 397.78%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-63.53%
Negative OCF growth while 0259.HK is at 41.96%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-57.45%
Negative FCF growth while 0259.HK is at 35.88%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-51.09%
Negative 10Y revenue/share CAGR while 0259.HK stands at 52.21%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.87%
5Y revenue/share CAGR under 50% of 0259.HK's 38.98%. Michael Burry would suspect a significant competitive gap or product weakness.
-51.44%
Negative 3Y CAGR while 0259.HK stands at 66.45%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2256.08%
Negative 10Y OCF/share CAGR while 0259.HK stands at 127.11%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-2477.32%
Negative 5Y OCF/share CAGR while 0259.HK is at 178.30%. Joel Greenblatt would question the firm’s operational model or cost structure.
5.55%
3Y OCF/share CAGR under 50% of 0259.HK's 393.76%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-9.39%
Negative 10Y net income/share CAGR while 0259.HK is at 689.68%. Joel Greenblatt sees a major red flag in long-term profit erosion.
37.21%
Below 50% of 0259.HK's 638.29%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
153.00%
Below 50% of 0259.HK's 433.33%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
65.53%
Below 50% of 0259.HK's 180.92%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
71.18%
5Y equity/share CAGR above 1.5x 0259.HK's 46.79%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-9.27%
Negative 3Y equity/share growth while 0259.HK is at 44.22%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-99.92%
Cut dividends over 10 years while 0259.HK stands at 895.56%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-99.99%
Negative near-term dividend growth while 0259.HK invests at 426.53%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.71%
AR growth well above 0259.HK's 1.64%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.97%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-6.97%
Negative asset growth while 0259.HK invests at 5.69%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
6.25%
50-75% of 0259.HK's 8.43%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-16.11%
We’re deleveraging while 0259.HK stands at 58.34%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-32.73%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.